Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masataka Okamoto

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Leukemia Research|January 2, 2007
Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patientsNozomi Niitsu, Masataka Okamoto, Naoya Nakamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Phase I study of Rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphomaNozomi Niitsu, Miyuki Hayama, Masataka Okamoto, et al.
Leukemia & Lymphoma|October 27, 2006
Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphomaNozomi Niitsu, Masataka Okamoto, Naoto Tomita, et al.
British Journal of Haematology|April 16, 2011
Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkersNozomi Niitsu, Miyuki Hayama, Tadashi Yoshino, et al.
Leukemia Research|August 5, 2006
t(8;14)(q24;q32) in two patients with CD10-negative primary thyroid diffuse large B-cell lymphomaNozomi Niitsu, Masataka Okamoto, Tadashi Yoshino, et al.
British Journal of Haematology|November 18, 2003
Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphomaNozomi Niitsu, Hirokazu Nakamine, Masataka Okamoto, et al.
Annals of Hematology|September 3, 2010
A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapyNozomi Niitsu, Jun-Ichi Tamaru, Tadashi Yoshino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Clinical significance of intracytoplasmic nm23-H1 expression in diffuse large B-cell lymphomaNozomi Niitsu, Hirokazu Nakamine, Masataka Okamoto, et al.
Pathology International|July 1, 2009
Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphomaHiroshi Imai, Kazuyuki Shimada, Satoko Shimada, et al.
Genes, Chromosomes & Cancer|November 7, 2003
Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridizationSivasundaram Karnan, Hiroyuki Tagawa, Ritsuro Suzuki, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Leukemia Research|January 2, 2007
Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patientsNozomi Niitsu, Masataka Okamoto, Naoya Nakamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Phase I study of Rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphomaNozomi Niitsu, Miyuki Hayama, Masataka Okamoto, et al.
Leukemia & Lymphoma|October 27, 2006
Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphomaNozomi Niitsu, Masataka Okamoto, Naoto Tomita, et al.
British Journal of Haematology|April 16, 2011
Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkersNozomi Niitsu, Miyuki Hayama, Tadashi Yoshino, et al.
Leukemia Research|August 5, 2006
t(8;14)(q24;q32) in two patients with CD10-negative primary thyroid diffuse large B-cell lymphomaNozomi Niitsu, Masataka Okamoto, Tadashi Yoshino, et al.
British Journal of Haematology|November 18, 2003
Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphomaNozomi Niitsu, Hirokazu Nakamine, Masataka Okamoto, et al.
Annals of Hematology|September 3, 2010
A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapyNozomi Niitsu, Jun-Ichi Tamaru, Tadashi Yoshino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Clinical significance of intracytoplasmic nm23-H1 expression in diffuse large B-cell lymphomaNozomi Niitsu, Hirokazu Nakamine, Masataka Okamoto, et al.
Pathology International|July 1, 2009
Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphomaHiroshi Imai, Kazuyuki Shimada, Satoko Shimada, et al.
Genes, Chromosomes & Cancer|November 7, 2003
Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridizationSivasundaram Karnan, Hiroyuki Tagawa, Ritsuro Suzuki, et al.
Pageof 7